3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea has been researched along with Melanoma in 3 studies
*Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afanasyeva, D; Baryshnikova, M; Belyаvsky, A; Burova, O; Misyurin, V; Shprakh, Z; Vartanian, A | 1 |
| Akimov, MA; Gershanovich, ML | 1 |
| Borodkina, AG; Egorov, GN; Gorbunova, VA; Manziuk, LV; Orel, NF; Semina, OV | 1 |
1 trial(s) available for 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Melanoma
| Article | Year |
|---|---|
[Chemoimmunotherapy with dacarbazine and aranose combined with interferon-alpha in disseminated cutaneous melanoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Glycosides; Humans; Immunologic Factors; Interferon-alpha; Male; Melanoma; Methylnitrosourea; Middle Aged; Skin Neoplasms; Treatment Outcome | 2004 |
2 other study(ies) available for 3-(alpha-l-arabinopyranosyl)-1-methyl-1-nitrosourea and Melanoma
| Article | Year |
|---|---|
Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents.
Topics: Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbazoles; CD24 Antigen; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoglin; Fluorescent Dyes; Gene Expression; Glycosides; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Male; Melanoma; Methylnitrosourea; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Neovascularization, Pathologic; Nuclear Proteins; Phenotype; Phosphoprotein Phosphatases; Proto-Oncogene Proteins c-kit; Rhodamine 123; Tetraspanin 30 | 2017 |
[Aranoza -- a new Russian antineoplastic drug].
Topics: Antineoplastic Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Therapy, Combination; Glycosides; Humans; Infusions, Intra-Arterial; Interferon-alpha; Melanoma; Methylnitrosourea; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Time Factors | 2001 |